Olaf Prante

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 18

Top Topics

Epidermal Growth Factor Receptor

Reactive Oxygen Species

Positive Breast Cancer

Top Venues

Pharmaceuticals (Basel, Switzerland)

BioMed research international

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Friedel, Olaf Prante, Simone Maschauer
Radiosynthesis and Preclinical Evaluation of 18 F-Labeled Estradiol Derivatives with Different Lipophilicity for PET Imaging of Breast Cancer. Cancers 16 (15) (2024)
Anna Friedel, Olaf Prante, Simone Maschauer
Radiosynthesis and Preclinical Evaluation of 18 F-Labeled Estradiol Derivatives with Different Lipophilicity for PET Imaging of Breast Cancer. Cancers 16 (15) (2024)
Kim-Viktoria Bolik, Jan Hellmann, Simone Maschauer, Eduard Neu, Jürgen Einsiedel, Patrick Riss, Nora Vogg, Jörg König, Martin F Fromm, Harald Hübner, Peter Gmeiner, Olaf Prante
Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated 18 F-fluorination of boroxines, in vitro and initial in vivo evaluation. EJNMMI research 14 (1) (2024)
Ayça Tunçel, Simone Maschauer, Olaf Prante, Fatma Yurt
In Vitro Assessment of 177 Lu-Labeled Trastuzumab-Targeted Mesoporous Carbon@Silica Nanostructure for the Treatment of HER2-Positive Breast Cancer. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Ayça Tunçel, Simone Maschauer, Olaf Prante, Fatma Yurt
In Vitro Assessment of 177 Lu-Labeled Trastuzumab-Targeted Mesoporous Carbon@Silica Nanostructure for the Treatment of HER2-Positive Breast Cancer. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Matthias Ruopp, Sha Zhu, Rafael Worschech, Dorothee Haas, Simone Maschauer, Olaf Prante, Lorenz Meinel, Tessa Lühmann
Bioconjugation of a Fibroblast Activation Protein Targeted Interleukin-4. ACS biomaterials science & engineering (2023)
Lisa Schindler, Katrin Wohlfahrt, Lara Gluhacevic von Krüchten, Olaf Prante, Max Keller, Simone Maschauer
Neurotensin analogs by fluoroglycosylation at N<sup>ω</sup>-carbamoylated arginines for PET imaging of NTS1-positive tumors. Scientific reports 12 (1) (2022)
Gasper Gregoric, Anastasia Gaculenko, Lisa Nagel, Vanessa Popp, Simone Maschauer, Olaf Prante, Marc Saake, Georg Schett, Michael Uder, Stephan Ellmann, Aline Bozec, Tobias Bäuerle
Non-Invasive Characterization of Experimental Bone Metastasis in Obesity Using Multiparametric MRI and PET/CT. Cancers 14 (10) (2022)
Sandip S Shinde, Simone Maschauer, Olaf Prante
Sweetening Pharmaceutical Radiochemistry by 18F-Fluoroglycosylation: Recent Progress and Future Prospects. Pharmaceuticals (Basel, Switzerland) 14 (11) (2021)
Sandip S Shinde, Kim-Viktoria Bolik, Simone Maschauer, Olaf Prante
18F-Fluorination Using Tri-Tert-Butanol Ammonium Iodide as Phase-Transfer Catalyst: An Alternative Minimalist Approach. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Julian Ott, Mona M Spilhaug, Simone Maschauer, Waqas Rafique, Jimmy Erik Jakobsson, Karoline Hartvig, Harald Hübner, Peter Gmeiner, Olaf Prante, Patrick Johannes Riss
Pharmacological Characterization of Low-to-Moderate Affinity Opioid Receptor Agonists and Brain Imaging with 18F-Labeled Derivatives in Rats. Journal of medicinal chemistry 63 (17) (2020)
Jasmin Krüll, Stefanie K Fehler, Laura Hofmann, Natascha Nebel, Simone Maschauer, Olaf Prante, Peter Gmeiner, Harald Lanig, Harald Hübner, Markus R Heinrich
Synthesis, Radiosynthesis and Biological Evaluation of Buprenorphine-Derived Phenylazocarboxamides as Novel μ-Opioid Receptor Ligands. ChemMedChem 15 (13) (2020)
Roman Potemkin, Brigitte Strauch, Torsten Kuwert, Olaf Prante, Simone Maschauer
Development of 18F-Fluoroglycosylated PSMA-Ligands with Improved Renal Clearance Behavior. Molecular pharmaceutics 17 (3) (2020)
Simone Maschauer, Julian J Ott, Günther Bernhardt, Torsten Kuwert, Max Keller, Olaf Prante
18F-labelled triazolyl-linked argininamides targeting the neuropeptide Y Y1R for PET imaging of mammary carcinoma. Scientific reports 9 (1) (2019)
Steffen Daum, Johannes Toms, Viktor Reshetnikov, Hülya Gizem Özkan, Frank Hampel, Simone Maschauer, Amir Hakimioun, Frank Beierlein, Leopold Sellner, Michael Schmitt, Olaf Prante, Andriy Mokhir
Identification of Boronic Acid Derivatives as an Active Form of N-Alkylaminoferrocene-Based Anticancer Prodrugs and Their Radiolabeling with 18F. Bioconjugate chemistry 30 (4) (2019)
Simone Maschauer, Olaf Prante
Radiopharmaceuticals for imaging and endoradiotherapy of neurotensin receptor-positive tumors. Journal of labelled compounds & radiopharmaceuticals 61 (3) (2018)
Davide Amato, Fabio Canneva, Paul Cumming, Simone Maschauer, Dominik Groos, Jana Katharina Dahlmanns, Teja W Grömer, Lisa Chiofalo, Marc Dahlmanns, Fang Zheng, Kornhuber Johannes, Olaf Prante, Christian Alzheimer, Stephan von Hörsten, Christian P Müller
A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter. Molecular psychiatry 25 (9) (2018)
Johannes Toms, Viktor Reshetnikov, Simone Maschauer, Andriy Mokhir, Olaf Prante
Radiosynthesis of an 18 F-fluoroglycosylated aminoferrocene for in-vivo imaging of reactive oxygen species activity by PET. Journal of labelled compounds & radiopharmaceuticals 61 (14) (2018)
Roland Haubner, Simone Maschauer, Olaf Prante
PET radiopharmaceuticals for imaging integrin expression: tracers in clinical studies and recent developments. BioMed research international 2014 (2014)
Simone Maschauer, Olaf Prante
Sweetening pharmaceutical radiochemistry by (18)f-fluoroglycosylation: a short review. BioMed research international 2014 (2014)
Roland Haubner, Simone Maschauer, Jürgen Einsiedel, Iris E Eder, Christine Rangger, Peter Gmeiner, Irene J Virgolini, Olaf Prante
H-CRRETAWAC-OH, a lead structure for the development of radiotracer targeting integrin α5β1? BioMed research international 2014 (2014)
Olaf Prante, Roland Haubner, Patrick Riss, Bernd Neumaier
Recent trends in pharmaceutical radiochemistry for molecular PET imaging. BioMed research international 2014 (2014)